In vivo dosimetry in brachytherapy.

In vivo dosimetry (IVD) has been used in brachytherapy (BT) for decades with a number of different detectors and measurement technologies. However, IVD in BT has been subject to certain difficulties and complexities, in particular due to challenges of the high-gradient BT dose distribution and the large range of dose and dose rate. Due to these challenges, the sensitivity and specificity toward error detection has been limited, and IVD has mainly been restricted to detection of gross errors. Given these factors, routine use of IVD is currently limited in many departments. Although the impact of potential errors may be detrimental since treatments are typically administered in large fractions and with high-gradient-dose-distributions, BT is usually delivered without independent verification of the treatment delivery. This Vision 20/20 paper encourages improvements within BT safety by developments of IVD into an effective method of independent treatment verification.

[1]  R. Pötter,et al.  Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  D Baltas,et al.  In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer. , 2003, International journal of radiation oncology, biology, physics.

[3]  T. Nose,et al.  In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter. , 2005, International journal of radiation oncology, biology, physics.

[4]  Kari Tanderup,et al.  Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy. , 2009, Medical physics.

[5]  Marinus A Moerland,et al.  Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  J. Borrás,et al.  Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Luc Beaulieu,et al.  The evolution of brachytherapy treatment planning. , 2009, Medical physics.

[8]  Kari Tanderup,et al.  Stem signal suppression in fiber-coupled Al2O3:C dosimetry for 192Ir brachytherapy , 2011 .

[9]  J Duan,et al.  In vivo urethral dose measurements: a method to verify high dose rate prostate treatments. , 2000, Medical physics.

[10]  C. Smith,et al.  The treatment of cervix cancer using high activity 60 Co sources. , 1972, The British journal of radiology.

[11]  A. Brahme,et al.  Comparative dosimetry in narrow high-energy photon beams. , 2000, Physics in medicine and biology.

[12]  J. Jassem,et al.  EPR/alanine dosimetry in LDR brachytherapy--a feasibility study. , 2006, Radiation protection dosimetry.

[13]  F. H. Attix,et al.  Water-equivalent plastic scintillation detectors for high-energy beam dosimetry: II. Properties and measurements. , 1992, Physics in medicine and biology.

[14]  D. Georg,et al.  In-vivo dosimetry for gynaecological brachytherapy: physical and clinical considerations. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  J J Prete,et al.  Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[16]  Michael C Kirk,et al.  Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachy radiotherapy. , 2004, Medical physics.

[17]  P. Lambin,et al.  In vivo dosimetry using a linear Mosfet-array dosimeter to determine the urethra dose in 125I permanent prostate implants. , 2009, International journal of radiation oncology, biology, physics.

[18]  J. Dimopoulos,et al.  Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  N Suchowerska,et al.  A plastic scintillation dosimeter for high dose rate brachytherapy , 2006, Physics in medicine and biology.

[20]  Sören Mattsson,et al.  Prevention of accidental exposures to patients undergoing radiation therapy , 2000 .

[21]  H. O. Wyckoff,et al.  The International Commission on Radiation Units and Measurements , 2001, Journal of the ICRU.

[22]  C. De Angelis,et al.  Alanine/EPR dosimetry in brachytherapy. , 1999, Physics in medicine and biology.

[23]  R. Alecu,et al.  In-vivo rectal dose measurements with diodes to avoid misadministrations during intracavitary high dose rate brachytherapy for carcinoma of the cervix. , 1999, Medical physics.

[24]  Natalka Suchowerska,et al.  Clinical trials of a urethral dose measurement system in brachytherapy using scintillation detectors. , 2011, International journal of radiation oncology, biology, physics.

[25]  L. Dewerd,et al.  Response of an implantable MOSFET dosimeter to Ir192 HDR radiation. , 2008, Medical physics.

[26]  Y. Akino,et al.  Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): patterns of care study in Japan. , 2008, International journal of radiation oncology, biology, physics.

[27]  Nilendu Gupta,et al.  The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. , 2001, International journal of radiation oncology, biology, physics.

[28]  J. Williamson,et al.  Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. , 2012, Medical physics.

[29]  M. Anton,et al.  In vivo dosimetry in the urethra using alanine/ESR during 192Ir HDR brachytherapy of prostate cancer—a phantom study , 2009, Physics in medicine and biology.

[30]  D. Kuban,et al.  Toward a real-time in vivo dosimetry system using plastic scintillation detectors. , 2010, International journal of radiation oncology, biology, physics.

[31]  C. Lodwick.  Clinical Dosimetry Measurements in Radiotherapy , 2011 .

[32]  R. Pötter,et al.  GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  Philippe Lambin,et al.  In vivo dosimetry with a linear MOSFET array to evaluate the urethra dose during permanent implant brachytherapy using iodine-125. , 2009, International journal of radiation oncology, biology, physics.

[34]  J Balosso,et al.  Radiotherapy quality assurance by individualized in vivo dosimetry: state of the art. , 2009, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

[35]  New method for shielding electron beams used for head and neck cancer treatment. , 1993, Medical physics.

[36]  Abdelhamid Saoudi,et al.  Feasibility study of using MOSFET detectors for in vivo dosimetry during permanent low-dose-rate prostate implants. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  O. Baffa,et al.  Ir-192 HDR transit dose and radial dose function determination using alanine/EPR dosimetry , 2005, Physics in medicine and biology.

[38]  Jan-Jakob Sonke,et al.  3D in vivo dose verification of entire hypo-fractionated IMRT treatments using an EPID and cone-beam CT. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[39]  F. Verhaegen,et al.  Influence of trace elements in human tissue in low-energy photon brachytherapy dosimetry , 2012, Physics in medicine and biology.

[40]  Tommy Knöös,et al.  Radiation Oncology Safety Information System (ROSIS)--profiles of participants and the first 1074 incident reports. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  L. Beaulieu,et al.  Development of a novel multi-point plastic scintillation detector with a single optical transmission line for radiation dose measurement , 2012, Physics in medicine and biology.

[42]  Bruce Thomadsen,et al.  American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. , 2012, Brachytherapy.

[43]  Ji-Hong Hong,et al.  Clinical application of radiophotoluminescent glass dosimeter for dose verification of prostate HDR procedure. , 2008, Medical Physics (Lancaster).

[44]  J. W. Winston,et al.  Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. , 2008, Medical physics.

[45]  Wayne M Butler,et al.  American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. , 2012, Brachytherapy.

[46]  P. Metcalfe,et al.  In vivo real-time dosimetric verification in high dose rate prostate brachytherapy. , 2011, Medical physics.

[47]  Steffen Greilich,et al.  Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy. , 2009, Medical physics.

[48]  E G Yukihara,et al.  Optically stimulated luminescence (OSL) dosimetry in medicine , 2008, Physics in medicine and biology.

[49]  S. Beddar.  On possible temperature dependence of plastic scintillator response. , 2012, Medical physics.

[50]  W. E. Liversage,et al.  Part I. Technique , 1967 .

[51]  M van Herk,et al.  Catching errors with in vivo EPID dosimetry. , 2010, Medical physics.

[52]  C. Deehan.  Dose and Volume Specification for Reporting in Interstitial Therapy , 1998 .

[53]  E. S. Bergstrand,et al.  Radiation dose measurements with alanine/agarose gel and thin alanine films around a 192Ir brachytherapy source, using ESR spectroscopy. , 2002, Physics in medicine and biology.

[54]  D Huyskens,et al.  Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification with in vivo dosimetry. , 2010, The British journal of radiology.

[55]  J. Cygler,et al.  Clinical use of a novel in vivo 4D monitoring system for simultaneous patient motion and dose measurements. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[56]  Dimos Baltas,et al.  4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery. , 2011, Medical physics.

[57]  Ken Yoshida,et al.  Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. , 2010, Brachytherapy.

[58]  J. Lambert,et al.  In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector. , 2007, Medical physics.

[59]  F. Verhaegen,et al.  In vivo dosimetry for gynaecological brachytherapy using a novel position sensitive radiation detector: feasibility study. , 2012, Medical physics.

[60]  Frank Verhaegen,et al.  Influence of breast composition and interseed attenuation in dose calculations for post-implant assessment of permanent breast 103Pd seed implant. , 2010, Physics in medicine and biology.

[61]  Jan Seuntjens,et al.  4D dose-position verification in radiation therapy using the RADPOS system in a deformable lung phantom. , 2010, Medical physics.

[62]  Louis Archambault,et al.  Measurement accuracy and cerenkov removal for high performance, high spatial resolution scintillation dosimetry. , 2005, Medical physics.

[63]  Ben Mijnheer,et al.  In vivo dosimetry in external beam radiotherapy. , 2013, Medical physics.

[64]  M. Aghili,et al.  Evaluation of treatment planning system of brachytherapy according to dose to the rectum delivered. , 2012, Radiation protection dosimetry.

[65]  K. Tanderup,et al.  Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[66]  T. Teshima,et al.  Patterns of radiotherapy practice for patients with cervical cancer in Japan, 2003-2005: changing trends in the pattern of care process. , 2012, International journal of radiation oncology, biology, physics.

[67]  Kari Tanderup,et al.  Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[68]  L. Beaulieu,et al.  A phantom study of an in vivo dosimetry system using plastic scintillation detectors for real-time verification of 192Ir HDR brachytherapy. , 2011, Medical physics.

[69]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2003, Medical physics.

[70]  J. Valentin.  Prevention of high-dose-rate brachytherapy accidents , 2005 .

[71]  B. Ciesielski,et al.  In vivo alanine/EPR dosimetry in daily clinical practice: a feasibility study. , 2003, International journal of radiation oncology, biology, physics.

[72]  Gerry Lowe,et al.  Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[73]  F. H. Attix,et al.  Water-equivalent plastic scintillation detectors for high-energy beam dosimetry: I. Physical characteristics and theoretical consideration. , 1992, Physics in medicine and biology.

[74]  L. Blank,et al.  Safety aspects of pulsed dose rate brachytherapy: analysis of errors in 1,300 treatment sessions. , 2008, International journal of radiation oncology, biology, physics.

[75]  R. Pötter,et al.  Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[76]  Natalka Suchowerska,et al.  Plastic scintillation dosimetry for radiation therapy: minimizing capture of Cerenkov radiation noise. , 2004, Physics in medicine and biology.

[77]  Larry A DeWerd,et al.  Determination of exit skin dose for I192r intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters. , 2010, Medical physics.

[78]  Evaluation of a novel 4D in vivo dosimetry system. , 2009, Medical physics.

[79]  T. Major,et al.  Dosimetric characteristics of accelerated partial breast irradiation with CT image--based multicatheter interstitial brachytherapy: a single institution's experience. , 2011, Brachytherapy.

[80]  In vivo dosimetry of high-dose-rate interstitial brachytherapy in the pelvic region: use of a radiophotoluminescence glass dosimeter for measurement of 1004 points in 66 patients with pelvic malignancy. , 2008, International journal of radiation oncology, biology, physics.

[81]  W. E. Liversage,et al.  The treatment of uterine carcinoma using the Cathetron. Part I. Technique. , 1967, The British journal of radiology.

[82]  Claus E Andersen,et al.  Characterizing a pulse-resolved dosimetry system for complex radiotherapy beams using organic scintillators , 2011, Physics in medicine and biology.

[83]  Ben Mijnheer,et al.  State of the art of in vivo dosimetry. , 2008, Radiation protection dosimetry.

[84]  J F Williamson,et al.  TLD, diode and Monte Carlo dosimetry of an 192Ir source for high dose-rate brachytherapy. , 1995, Physics in medicine and biology.

[85]  R. Chawla,et al.  Absolute depth-dose-rate measurements for an 192Ir HDR brachytherapy source in water using MOSFET detectors. , 2006, Medical physics.

[86]  F. Verhaegen,et al.  Consequences of dose heterogeneity on the biological efficiency of 103Pd permanent breast seed implants , 2012, Physics in medicine and biology.

[87]  B. Erickson,et al.  American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. , 2005, International journal of radiation oncology, biology, physics.

[88]  S. McKeever,et al.  Recent advances in dosimetry using the optically stimulated luminescence of Al2O3:C. , 2004, Radiation protection dosimetry.

[89]  C. Haie-meder,et al.  Overview of brachytherapy resources in Latin America: a patterns-of-care survey. , 2011, Brachytherapy.

[90]  Alex Rijnders,et al.  Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[91]  Tomas Kron,et al.  An in vivo investigative protocol for HDR prostate brachytherapy using urethral and rectal thermoluminescence dosimetry. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[92]  R. Sarin,et al.  Clinical application of a OneDose™ MOSFET for skin dose measurements during internal mammary chain irradiation with high dose rate brachytherapy in carcinoma of the breast , 2006, Physics in medicine and biology.

[93]  p-type silicon detector for brachytherapy dosimetry. , 1995, Medical physics.

[94]  T. Kron,et al.  Thermoluminescence dosimetry for in-vivo verification of high dose rate brachytherapy for prostate cancer , 2007, Australasian Physics & Engineering Sciences in Medicine.

[95]  J. Cygler,et al.  Commissioning and quality assurance of treatment planning computers. , 1993, International journal of radiation oncology, biology, physics.

[96]  M van Herk,et al.  Catching errors with in vivo EPID dosimetry. , 2010, Medical physics.

[97]  Y. Garces,et al.  Model-based dose calculations for 125 I lung brachytherapy. , 2012, Medical physics.

[98]  G. Stuecklschweiger,et al.  Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[99]  J Cygler,et al.  Evaluation of a dual bias dual metal oxide-silicon semiconductor field effect transistor detector as radiation dosimeter. , 1994, Medical physics.

[100]  JAICRP 157p.  Prevention of Accidental Exposures to Patients Undergoing Radiation Therapy , 2000, Annals of the ICRP.

[101]  J. Lambert,et al.  Dose mapping of the rectal wall during brachytherapy with an array of scintillation dosimeters. , 2010, Medical physics.